Publications
470
Citations
14,673
Est. group size
~18
Recurring co-author estimate
Active years
28
Publishing since 1999
Typically publishes in teams of ~14 · 2% small-team papers (≤3 authors) · across 26 venues
- Alopecia following single-dose postoperative intravesical gemcitabine in nonmuscle-invasive bladder cancer: A multi-institutional case series
Urologic Oncology Seminars and Original Investigations · 2026
- Concordance between clinical, genomic, and AI-based risk stratification in prostate cancer.
Journal of Clinical Oncology · 2026
- Prevalence and clinical impact of actionable genomic alterations in non–clear cell renal cell carcinoma: A review of NGS-based trials and real-world data.
Journal of Clinical Oncology · 2026
- IP61-01 AI IN THE INBOX: IMPLEMENTATION, UTILIZATION, AND PHYSICIAN EXPERIENCE WITH LARGE LANGUAGE MODEL–GENERATED DRAFTS IN UROLOGY
The Journal of Urology · 2026
- Utilization of a Virtual Tumor Board for the Care of Patients With Renal Masses: Experience From a Quality Improvement Collaborative
Urology Practice · 2023
- Positive surgical margins in partial nephrectomy: a collaborative effort to maintain surgical quality
British Journal of Urology · 2023
- Supplementary Tables S1-S4 from Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy
2023
- Survival prediction for patients with metastatic urothelial cancer after immunotherapy by machine learning
2023
- Supplementary Figure Legends from Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy
2023
- Data from Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy
2023
- Supplementary Figures S1-S5 from Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy
2023
- Data from Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy
2023
- Supplementary Methods and References from Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy
2023
- Data from Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression
2023
- Supplementary Methods, Figures 1-5, Tables 1-11 from Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression
2023
- The Journal of Urology×64
- Urology×14
- Urologic Oncology Seminars and Original Investigations×11
- Journal of Clinical Oncology×7
- European Urology×6
- Courtney Yong
Medicine · Indiana University
- Debra L. Zynger
Medicine · The Ohio State University
- Shawn Dason
Medicine · The Ohio State University
- Khaled Hafez
Medicine · University of Michigan
- Cheryl T. Lee
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile